Nothing Special   »   [go: up one dir, main page]

ES483711A1 - Procedimiento para la preparacion de nuevos 4-hidroxi-2h-(1)benzotieno(2,3-c)-1,2-tiazin-3-carboxamido-1,1-dioxidos - Google Patents

Procedimiento para la preparacion de nuevos 4-hidroxi-2h-(1)benzotieno(2,3-c)-1,2-tiazin-3-carboxamido-1,1-dioxidos

Info

Publication number
ES483711A1
ES483711A1 ES483711A ES483711A ES483711A1 ES 483711 A1 ES483711 A1 ES 483711A1 ES 483711 A ES483711 A ES 483711A ES 483711 A ES483711 A ES 483711A ES 483711 A1 ES483711 A1 ES 483711A1
Authority
ES
Spain
Prior art keywords
carbon atoms
hydroxy
benzothieno
preparation
denotes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES483711A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of ES483711A1 publication Critical patent/ES483711A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D333/70Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)

Abstract

Procedimiento para la preparación de nuevos 4-hidroxi- 2H[1]benzotieno[2,3-e]-1,2-tiazin-3-carboxamido-1,1-dióxidos de la fórmula general **(Fórmula)** en la que R1 significa un átomo de hidrógeno o de halógeno o un grupo alcohilo con 1 a 3 átomos de carbono, R2 significa un átomo de hidrógeno o un grupo alcohilo con 1 a 3 átomos de carbono, y R3 significa un radical hidrocarbonado aromático con 6 a 10 átomos de carbono o un radical heteroaromático con 2 a 9 átomos de carbono que contiene 1 ó 2 átomos de nitrógeno y/o un átomo de oxígeno o de azufre, pudiendo estar sustituidos los radicales aromáticos antes mencionados con 1 ó 2 radicales alochilo de 1 a 6 átomos de carbono, con un átomo de halógeno, con un grupo hidroxi, trifluorometilo o halógenofenilo o con un grupo alcoxi con 1-3 átomos de carbono, y de sus sales fisiológicamente compatibles con bases orgánicas o inorgánicas.
ES483711A 1978-09-02 1979-08-29 Procedimiento para la preparacion de nuevos 4-hidroxi-2h-(1)benzotieno(2,3-c)-1,2-tiazin-3-carboxamido-1,1-dioxidos Expired ES483711A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782838377 DE2838377A1 (de) 1978-09-02 1978-09-02 Neue 4-hydroxy-2h eckige klammer auf 1 eckige klammer zu benzothieno eckige klammer auf 2,3-e eckige klammer zu -1,2- thiazin-3-carboxamid-1,1-dioxide sowie deren salze, deren verwendung und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
ES483711A1 true ES483711A1 (es) 1980-04-16

Family

ID=6048562

Family Applications (1)

Application Number Title Priority Date Filing Date
ES483711A Expired ES483711A1 (es) 1978-09-02 1979-08-29 Procedimiento para la preparacion de nuevos 4-hidroxi-2h-(1)benzotieno(2,3-c)-1,2-tiazin-3-carboxamido-1,1-dioxidos

Country Status (14)

Country Link
US (1) US4259336A (es)
EP (1) EP0009142A1 (es)
JP (1) JPS5535086A (es)
AU (1) AU5046679A (es)
DE (1) DE2838377A1 (es)
DK (1) DK365879A (es)
ES (1) ES483711A1 (es)
FI (1) FI792721A (es)
GR (1) GR69999B (es)
IL (1) IL58155A0 (es)
NO (1) NO792828L (es)
PT (1) PT70134A (es)
YU (1) YU212279A (es)
ZA (1) ZA794618B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5811280A (en) * 1979-06-13 1980-12-18 F. Hoffmann-La Roche Ag Thiazine derivatives
GR80576B (en) * 1983-10-17 1984-11-29 Fujisawa Pharmaceutical Co Thiazine derivatives, process for preparation thereof and pharmaceutical composition comprising the same
US4683306A (en) * 1984-07-13 1987-07-28 Yuhan Corporation Co., Ltd. Process for the preparation of 3,4-dihydro-2-substituted-2H-1,2-thiazine-carboxylic acid 1,1-dioxide derivatives
JP2690742B2 (ja) * 1987-03-30 1997-12-17 第一製薬株式会社 複素環アミン誘導体
US4914101A (en) * 1987-06-10 1990-04-03 Pfizer Inc. 3,4-Dihydro-2-alkyl-3-oxo-n-aryl-2H-(1)benzo-thieno(3,2-e)-1,2-thiazine-4-carboxamide-1,1-dioxides
EP1384723A1 (de) * 2002-07-26 2004-01-28 Boehringer Ingelheim Pharma GmbH & Co.KG Neue 4-Hydroxy-2H-thieno[2,3-e]-1,2-thiazin-3-carboxamid-1,1-dioxide, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL47877A (en) * 1974-08-26 1978-10-31 Sparamedica Ag Thienothiazine carboxamide derivatives,their manufacture and pharmaceutical compositions containing them
DE2539112C2 (de) * 1975-09-03 1983-12-15 Dr. Karl Thomae Gmbh, 7950 Biberach 4-Hydroxy-2H-naphtho[2,1-e]-1,2-thiazin-3-carboxamid-1,1-dioxide, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2452946A1 (de) * 1974-11-08 1976-05-13 Merck Patent Gmbh Pyrazolidinone und verfahren zu ihrer herstellung
SU623520A3 (ru) * 1976-09-07 1978-09-05 Ф.Гоффанн-Ля Рош И Ко Аг, (Фирма) Способ получени производных тиенотиазина
DE2704485A1 (de) * 1977-02-03 1978-08-10 Thomae Gmbh Dr K Neue 2,5-dihydro-1,2-thiazino eckige klammer auf 5,6-b eckige klammer zu indol-3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
AU518216B2 (en) * 1977-09-06 1981-09-17 Hafslund Nycomed Pharma Aktiengesellschaft Thienothiazine derivatives

Also Published As

Publication number Publication date
DE2838377A1 (de) 1980-03-20
DK365879A (da) 1980-03-03
JPS5535086A (en) 1980-03-11
IL58155A0 (en) 1979-12-30
GR69999B (es) 1982-07-23
ZA794618B (en) 1981-05-27
YU212279A (en) 1983-01-21
AU5046679A (en) 1980-03-13
FI792721A (fi) 1980-03-03
US4259336A (en) 1981-03-31
NO792828L (no) 1980-03-04
PT70134A (de) 1979-09-01
EP0009142A1 (de) 1980-04-02

Similar Documents

Publication Publication Date Title
CO4440628A1 (es) Derivados de pirimidina condensados con un anillo heteroci- clico
MX9203258A (es) Amidas de acidos tieno-triazol-1,4-diazepino-2-carboxilicos y composiciones farmaceuticas que los contienen.
LV11690A (lv) Tetracikliski atvasinajumi izgatavosanas panemiens un izmantosana
ES2080919T3 (es) Nuevos derivados de bencimidazol y de azabencimidazol, antagonistas de los receptores al tromboxano, sus procedimientos de preparacion, intermediarios de sintesis, composiciones que los contienen.
ES2062458T3 (es) Derivados del 1,2-benzisoxazol, sus procedimientos de preparacion y las composiciones farmaceuticas que los contienen.
AR012622A1 (es) Inhibidores de proteasas, procedimiento para su preparacion, composicion farmaceutica que los comprende y el uso de los mismos en la fabricacion de unmedicamento
ES483711A1 (es) Procedimiento para la preparacion de nuevos 4-hidroxi-2h-(1)benzotieno(2,3-c)-1,2-tiazin-3-carboxamido-1,1-dioxidos
ES2036213T3 (es) Procedimiento para preparar derivados tetrahidroisoquinolin-1-ilicos de acidos carboxilicos.
HUP0004142A2 (hu) 5-HT1F agonista hatású karboxamidszármazékok és a vegyületeket tartalmazó gyógyászati készítmények
ES2012648A6 (es) Procedimiento para la preparacion de nuevos derivados de 1,4-benzoxazina y 1,4-benzotiazina.
ES2055717T3 (es) Derivados de benzo- y tieno-3,4-dihidro-piridina, procedimientos para su preparacion y medicamentos que contienen estos compuestos.
DK415789D0 (da) Tetracykliske antidepressive midler
DK248788D0 (da) Bicycliske sulfonamidderivater samt fremgangsmaade til fremstilling deraf
DK412082A (da) 2-amino-1,2,3,4-tetrahydro-naphthalenderivater, fremgangsmaade til deres fremstilling samt deres anvendelse
MX17338A (es) Sulfonamidas y procedimiento para su preparacion.
DE3866719D1 (de) Verwendung von oxochinazolinderivaten bei der behandlung von hyperurikaemie.
ES477517A1 (es) Procedimiento para la preparacion de nuevos derivados car- bostirilicos y oxindolicos.
DK161186D0 (da) Dibenzo(be)oxepineddikesyre-derivater samt fremgangsmaade til fremstilling og anvendelse deraf
FI860424A (fi) Kinolonfoereningar anvaendbara som inotropiska aemnen.
ES510739A0 (es) "procedimiento para la preparacion de 1,1-dioxidos de 4-hidroxi-1,2-benzoisotiazol-3(2h)-ona".
ES509555A0 (es) "procedimiento para la preparacion de nuevas cefalosporinas".
ATE117671T1 (de) Aminoketonverbindungen.
SE8500451D0 (sv) N-substituted amino propane sulfonic acid derivatives
AR034452A2 (es) N-oxidos de heterociclos saturados que contienen nitrogeno y que estan sustituidos con quinoloncarboxilicos y procedimiento para su produccion.
ES465840A1 (es) Procedimiento para la preparacion de nuevos derivados de anilinometilenmalonitrilo